![Pharmaceuticals policy / Pharmacy / Pharmaceutical industry / Drugs / Healthcare reform in the United States / Medicare / Prescription drug / Prescription costs / Pharmaceutical drug / Prescription drug prices in the United States / Medicare Part D Pharmaceuticals policy / Pharmacy / Pharmaceutical industry / Drugs / Healthcare reform in the United States / Medicare / Prescription drug / Prescription costs / Pharmaceutical drug / Prescription drug prices in the United States / Medicare Part D](https://www.pdfsearch.io/img/53fcf0c84abdb3b64e4b2820177a374b.jpg) Date: 2015-11-30 09:15:16Pharmaceuticals policy Pharmacy Pharmaceutical industry Drugs Healthcare reform in the United States Medicare Prescription drug Prescription costs Pharmaceutical drug Prescription drug prices in the United States Medicare Part D | | November 2015 INTRODUCTION A new poll of adults in the United States by STAT and Harvard T.H. Chan School of Public Health finds that public concerns about the unreasonableness of brand-name prescription drug prices isAdd to Reading ListSource URL: cdn1.sph.harvard.eduDownload Document from Source Website File Size: 946,99 KBShare Document on Facebook
|